Drugs Controller General of India (DCGI)

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

New Delhi: Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinic...Read More

Coronavirus in Maharashtra: State govt to procure Itolizumab to treat moderate to severe cases

Coronavirus in Maharashtra: State govt to procure Itolizumab to treat moderate to severe cases

The Maharashtra government, which is struggling to curb the COVID-19 pandemic, has decided to procure Itolizumab (a monoclonal antibody) ...Read More

DCGI gives nod for 'restricted emergency use' of Itolizumab for moderate to severe COVID-19 patients

DCGI gives nod for 'restricted emergency use' of Itolizumab for moderate to severe COVID-19 patients

Mumbai: Itolizumab (rDNA origin), a monoclonal antibody which was already approved for severe chronic plaque psoriasis, has now been gran...Read More

Market Update: Rupee jumps 44 paise to 74.60 against US dollar in early trade

Market Update: Rupee jumps 44 paise to 74.60 against US dollar in early trade

Mumbai: The rupee appreciated 44 paise to 74.60 against the US dollar in early trade on Friday tracking weakness in the greenback and gai...Read More

Free Press Journal

www.freepressjournal.in